Filing metadata

Accession number
0001562180-21-003017
Form type
Form 3
Filer
Foghorn Therapeutics Inc.
CIK
CIK 1822462
Filed
Apr 29, 2021
Reporting period
Apr 27, 2021
Description
Initial ownership

Explore SEC Filings Hub